Executive Director Immunology Translational Sciences, Johnson & Johnson Innovative Medicine
BIOGRAPHY
Date: June 17, 2025 Time: 8:00 AM (PT), 11:00 AM (ET), 17:00 (CET)
From Insight to Impact: A Conversation on the Strategic Role of Biomarkers in Drug Discovery and Clinical Trials
Speakers
-
Magnus Althage
Head of the Translational Science & Experimental Medicine Strategy Group in CVRM, AstraZeneca R&DBIOGRAPHY -
Jen-Chieh Chuang
Director, GPL & Translational Biomarker Lead, Liver Diseases, Takeda PharmaceuticalsBIOGRAPHY
Event Date & Time
Date: June 17, 2025
Time: 8:00 AM (PT), 11:00 AM (ET), 17:00 (CET)
Abstract
Biomarkers are no longer just exploratory tools-they're becoming strategic assets in drug development and clinical trials. Join a panel of industry thought leaders as they explore how biomarkers are being integrated across the drug development pipeline and clinical trials to reduce risk, improve success rates, accelerate timelines, and ultimately enhance patient outcomes.
Our panelists: Magnus Althage, Head of the Translational Science & Experimental Medicine Strategy Group in CVRM, AstraZeneca R&D Dawn Waterworth, Senior Director, Johnson & Johnson Innovative Medicine
The discussion will be moderated by Ray Chen, Global Sr. Director of Strategic Accounts in Olink Proteomics (part of Thermo Fisher Scientific), who will also share his observations on global trends for integrating protein biomarker tools in drug discovery and clinical trial design.
Learning Objectives
- Understand the increasingly strategic role of biomarkers in drug discovery and clinical trials
- Learn how biomarker strategies can reduce risk, improve trial efficiency, and drive pipeline success in drug discovery and clinical trials.
- Explore real-world applications of biomarkers in exploratory biomarker identification and drug profiling for clinical efficacy, safety, and Mechanism of action (MOA).
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 14, 2025 | 10:00 AM
Stem cells and organoids are revolutionising medical advancements. The journey from stem cell research to translational medicine is extensive, and maintaining quality throughout development...
OCT 14, 2025 | 9:00 AM
Current guidelines by the International Myeloma Working Group and College of American Pathologists recommend performing serum protein electrophoresis (SPEP) and serum free light chain (sFLC)...
OCT 15, 2025 8:30 AM IST | 11 AM SGT | 12PM Korea, Japan | 2 PM AEST
Due to its high accuracy and fast, simple workflow, capillary electrophoresis (CE) is a foundational technology for clinical applications. CE is an invaluable tool used to detect genetic var...
October 15, 2025 8:00 AM (PT), 11:00 AM (ET), 4:00 PM (CET)
When it comes to Western blotting (WB), there is a wide range of different detection methods, reagents, and imaging systems used within scientific communities. But what approach can help ens...
OCT 15, 2025 | 10:00 AM
The Cancer Gene Census (CGC) is a widely used module within the Catalogue Of Somatic Mutations In Cancer (COSMIC) that comprises an ongoing effort to catalogue and describe all genes with ca...
OCT 15, 2025 | 1:00 PM
Join us for an exclusive behind-the-scenes look at the newest Thermo Scientific Vanquish HPLC & UHPLC Systems enhancements, re-designed based on customer needs and feedback. Discover how...
Loading Comments...